These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

334 related articles for article (PubMed ID: 15770639)

  • 1. Langerhans cell histiocytosis in neonates.
    Minkov M; Prosch H; Steiner M; Grois N; Pötschger U; Kaatsch P; Janka-Schaub G; Gadner H
    Pediatr Blood Cancer; 2005 Nov; 45(6):802-7. PubMed ID: 15770639
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pulmonary Langerhans cell histiocytosis: a variable disease in childhood.
    Odame I; Li P; Lau L; Doda W; Noseworthy M; Babyn P; Weitzman S
    Pediatr Blood Cancer; 2006 Dec; 47(7):889-93. PubMed ID: 16276522
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of multisystem Langerhans cell histiocytosis. Results of the DAL-HX 83 and DAL-HX 90 studies. DAL-HX Study Group.
    Minkov M; Grois N; Heitger A; Pötschger U; Westermeier T; Gadner H
    Klin Padiatr; 2000; 212(4):139-44. PubMed ID: 10994540
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hungarian experience with Langerhans cell histiocytosis in childhood.
    Müller J; Garami M; Hauser P; Schuler D; Csóka M; Kovács G; Rényi I; Kovács G; Marosi A; Galántai I; Békési A; Kajtár P; Kiss CS; Nagy K; Bartyik K; Masáth P; Kriván G;
    Pediatr Hematol Oncol; 2006 Mar; 23(2):135-42. PubMed ID: 16651242
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Experiences with Langerhans' cell histiocytosis in children in Hungary].
    Müller J; Koós R; Garami M; Hauser P; Borgulya G; Schuler D; Benyó G; Magyarosy E; Galántai I; Milei K; Török K; Bárdi E; Hunyadi K; Gábor K; Masáth P; Bodnár L; Kovács G
    Magy Onkol; 2004; 48(4):289-95. PubMed ID: 15655573
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Incidence of Langerhans cell histiocytosis in children: a population-based study.
    Stålemark H; Laurencikas E; Karis J; Gavhed D; Fadeel B; Henter JI
    Pediatr Blood Cancer; 2008 Jul; 51(1):76-81. PubMed ID: 18266220
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Descriptive epidemiology of childhood Langerhans cell histiocytosis in France, 2000-2004.
    Guyot-Goubin A; Donadieu J; Barkaoui M; Bellec S; Thomas C; Clavel J
    Pediatr Blood Cancer; 2008 Jul; 51(1):71-5. PubMed ID: 18260117
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reactivations in multisystem Langerhans cell histiocytosis: data of the international LCH registry.
    Minkov M; Steiner M; Pötschger U; Aricò M; Braier J; Donadieu J; Grois N; Henter JI; Janka G; McClain K; Weitzman S; Windebank K; Ladisch S; Gadner H;
    J Pediatr; 2008 Nov; 153(5):700-5, 705.e1-2. PubMed ID: 18589441
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cutaneous Langerhans cell histiocytosis in children under one year.
    Lau L; Krafchik B; Trebo MM; Weitzman S
    Pediatr Blood Cancer; 2006 Jan; 46(1):66-71. PubMed ID: 16261594
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Incidence and survival of childhood Langerhans cell histiocytosis in Northwest England from 1954 to 1998.
    Alston RD; Tatevossian RG; McNally RJ; Kelsey A; Birch JM; Eden TO
    Pediatr Blood Cancer; 2007 May; 48(5):555-60. PubMed ID: 16652350
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nationwide survey of single-system single site Langerhans cell histiocytosis in Japan.
    Morimoto A; Ishida Y; Suzuki N; Ohga S; Shioda Y; Okimoto Y; Kudo K; Ishii E;
    Pediatr Blood Cancer; 2010 Jan; 54(1):98-102. PubMed ID: 19728332
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of loss of heterozygosity in single-system and multisystem Langerhans' cell histiocytosis.
    Chikwava KR; Hunt JL; Mantha GS; Murphy JE; Jaffe R
    Pediatr Dev Pathol; 2007; 10(1):18-24. PubMed ID: 17378622
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improved outcome in the treatment of pediatric multifocal Langerhans cell histiocytosis: Results from the Japan Langerhans Cell Histiocytosis Study Group-96 protocol study.
    Morimoto A; Ikushima S; Kinugawa N; Ishii E; Kohdera U; Sako M; Fujimoto J; Bessho F; Horibe K; Tsunematsu Y; Imashuku S;
    Cancer; 2006 Aug; 107(3):613-9. PubMed ID: 16804933
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neonatal and early infantile cutaneous langerhans cell histiocytosis: comparison of self-regressive and non-self-regressive forms.
    Battistella M; Fraitag S; Teillac DH; Brousse N; de Prost Y; Bodemer C
    Arch Dermatol; 2010 Feb; 146(2):149-56. PubMed ID: 20157025
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 2'-Chlorodeoxyadenosine (2-CdA) as salvage therapy for Langerhans cell histiocytosis (LCH). results of the LCH-S-98 protocol of the Histiocyte Society.
    Weitzman S; Braier J; Donadieu J; Egeler RM; Grois N; Ladisch S; Pötschger U; Webb D; Whitlock J; Arceci RJ
    Pediatr Blood Cancer; 2009 Dec; 53(7):1271-6. PubMed ID: 19731321
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pattern and course of single-system disease in Langerhans cell histiocytosis data from the DAL-HX 83- and 90-study.
    Titgemeyer C; Grois N; Minkov M; Flucher-Wolfram B; Gatterer-Menz I; Gadner H
    Med Pediatr Oncol; 2001 Aug; 37(2):108-14. PubMed ID: 11496348
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Permanent consequences in Langerhans cell histiocytosis patients: a pilot study from the Histiocyte Society-Late Effects Study Group.
    Haupt R; Nanduri V; Calevo MG; Bernstrand C; Braier JL; Broadbent V; Rey G; McClain KL; Janka-Schaub G; Egeler RM
    Pediatr Blood Cancer; 2004 May; 42(5):438-44. PubMed ID: 15049016
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predictors of outcome in children with Langerhans cell histiocytosis.
    Jubran RF; Marachelian A; Dorey F; Malogolowkin M
    Pediatr Blood Cancer; 2005 Jul; 45(1):37-42. PubMed ID: 15768381
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fetal and neonatal histiocytoses.
    Isaacs H
    Pediatr Blood Cancer; 2006 Aug; 47(2):123-9. PubMed ID: 16416419
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reactivation and risk of sequelae in Langerhans cell histiocytosis.
    Pollono D; Rey G; Latella A; Rosso D; Chantada G; Braier J
    Pediatr Blood Cancer; 2007 Jun; 48(7):696-9. PubMed ID: 17252574
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.